AbbVie (ABBV) Change in Acquisitions & Divestments (2012 - 2025)

AbbVie has disclosed Change in Acquisitions & Divestments across 14 years of filings, most recently posting $34.0 million for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments fell 12.82% year-over-year to $34.0 million; the TTM figure through Dec 2025 stood at $76.0 million (down 86.31% YoY), while the FY2025 annual figure was $76.0 million, down 86.31% from the prior year.
• Change in Acquisitions & Divestments rose to $34.0 million in Q4 2025, from $3.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for ABBV reached as high as $1.4 billion in Q3 2022 and fell as low as $3.0 million in Q2 2024.
• The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2023), against an average of $115.7 million.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments tumbled 99.65% — and 2024, when it soared 10040.0%.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.0 million in 2021, then jumped by 600.0% to $70.0 million in 2022, then plunged by 80.0% to $14.0 million in 2023, then jumped by 178.57% to $39.0 million in 2024, then declined by 12.82% to $34.0 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $34.0 million, $3.0 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.